Evaluation of Serum Apolipoprotein E as a Potential Biomarker for Pharmacological Therapeutic Efficacy Monitoring in Dopamine Dictated Disease Spectrum of Schizophrenia and Parkinson’s disease: A Preliminary Study

AIM OF THE STUDY: Parkinson’s disease and schizophrenia are disease end points of dopaminergic deficit and hyperactivity, respectively, in the mid brain. Accordingly, current medications aim to restore normal dopamine levels, overshooting of which results in adverse effects of psychosis and extra-py...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cent Nerv Syst Dis
Main Authors: Gupta, Ashish Kumar, Rani, Komal, Swarnkar, Surabhi, Kumar, Gaurav Khunger, Khan, Mohd Imran, Pokhriyal, Ruchika, Kumar, Domada Ratna, Goyal, Vinay, Tripathi, Manjari, Gupta, Rishab, Chadda, Rakesh Kumar, Vanamail, Perumal, Hariprasad, Gururao
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6178121/
https://ncbi.nlm.nih.gov/pubmed/30327579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179573518803585
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados